Loading patent…
AssigneeUniversity of Central Lancashire
InventorsMatthew James BAKER, Peter ABEL, Robert William LEA
Estimating the term…
The present invention relates to methods of diagnosing and/or prognosing proliferative disorders, especially brain cancers (e.g. gliomas). In particular, the present invention provides a means to conveniently detect malignant tumours merely by assaying or analysing blood (particularly blood serum). Cytokines and/or angiogenesis factors in blood serum have been found to be surprisingly powerful at indicating the presence of brain cancers in a subject. Moreover, spectroscopic analysis, especially ATR-FTIR analysis, of a blood sample has been demonstrated to be surprisingly effective at producing a signature that can be correlated with the presence, extent, severity, or aggressiveness of malignant tumours in a subject.
-31. (canceled)
A method of diagnosing and/or prognosing a proliferative disorder in a subject, the method comprising performing spectroscopic analysis upon a blood sample or component thereof of the subject to produce a spectroscopic signature characteristic of the blood sample (or component thereof);
A diagnostic kit for diagnosing and/or prognosing a proliferative disorder in a subject, comprising a device configured to receive a blood sample or component thereof from the subject and to perform spectroscopic analysis upon the blood sample or component thereof of the subject to produce a spectroscopic signature characteristic of the blood sample or component thereof;
Dependencies are inferred from the claim text.